Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
NK Cell Therapy + Mogamulizumab for T-Cell Lymphoma/Leukemia
Recruiting2 awardsPhase 1
Columbus, Ohio
This trial is to find out the benefits and side effects of immunotherapy with natural killer cells in combination with a cancer-fighting antibody for patients with skin T-cell lymphoma or adult T-cell leukemia/lymphoma that has come back or does not respond to treatment.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.